Market News for Cvs Health Corp (CVS)
CVS Health said it will restore coverage of Eli Lilly's blockbuster weight loss injection Zepbound and start covering its new obesity pill on its standard drug plans. The move supports Lilly's efforts to maintain its dominance over Novo Nordisk in the blockbuster weight loss drug market, as it puts the two drugmakers on equal footing on major drug plans....
CNBC - 5/28/2026 6:45:03 AM
More News for CVS
Stock Analysis for CVS
Related Stocks:
